Prevalence of respiratory syncytial virus (RSV) risk factors and cost implications of immunoprophylaxis to infants 32 to 35 weeks gestation for health plans in the United States.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples